《大行報告》野村上調周大福(01929.HK)目標價至17.6元 評級「買入」
野村發表報告表示,周大福(01929.HK)管理層透露今年4至5月份內地業務同店銷售增長持續強勁,錄得按年49.3%的升幅,由於去年下半財年高基數因素下,該行維持其今年度同店銷售增長預測為6%;同時公司目標本財年在內地淨增700間店舖。
報告又指,周大福港澳業務方面,4至5月份同店銷售增長反彈至159.7%,主因由本地消費及低基數所帶動,更預期市場有見底反彈的跡象,故將其今年度同店銷售增長預測由15%升至35%。該行下調其本年度盈利預測4.5%,以反映較保守之毛利率預測,但料港澳市場反彈可作出彌補,目標價由16.1元上調至17.6元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.